Navigation Links
Ronald McDonald House Charities(R) (RMHC(R)) and McDonald's(R) Seek Inspiring Stories Through New 'Share.Give.Hope.' Campaign
Date:7/2/2009

OAK BROOK, Ill., July 2 /PRNewswire/ -- Thirty-five years ago, the first Ronald McDonald House(R) opened its doors in Philadelphia to provide a "home away from home" for families with seriously ill children. Today, McDonald's(R) and Ronald McDonald House Charities(R) (RMHC(R)) kick-off an anniversary celebration to commemorate this important milestone and their long-standing commitment to helping children and families in need worldwide.

"For 35 years, local McDonald's franchisees have come together to support families in need," said William Whitman, Jr., vice president, U.S. Communications, McDonald's USA. "McDonald's and our franchisees are proud of our long-standing relationship with RMHC and look forward to continuing our legacy of giving back to the communities that we serve."

Share Your Story Online

Beginning today, RMHC and McDonald's are inviting people to share their stories of how RMHC has touched their lives, the life of someone they know, or their personal stories of inspiration through a dedicated campaign page at www.rmhc.org/stories. Visitors can share and read personal accounts of hope and inspiration; post comments to stories listed on the site; and become part of a network of individuals who've been through similar experiences.

The anniversary celebration will culminate in November during McHappy Day(R), McDonald's largest annual fundraiser for the Charity. RMHC and McDonald's will feature one of the stories submitted online in a national print advertising campaign for RMHC, inspiring others to help support children and families around the world.

"It's amazing to think that what started as one house in Philadelphia has grown into a worldwide organization of nearly 300 Houses that families count on when their children are seriously ill," said Marty Coyne, president and CEO, Ronald McDonald Hou
'/>"/>

SOURCE McDonald's USA, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
2. St. Christophers Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost
3. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
4. Mayo Clinics Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
5. Philadelphia Ronald McDonald House(R) at Front & Erie Celebrates Grand Opening
6. MCM Completes Westwood Replacement Hospital - Ronald Reagan UCLA Medical Center
7. International Soccer Superstar Ronaldinho Signs With Nutrilite(TM)
8. Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
9. Los Angeles Ronald McDonald House Doubles Lodging Capacity for Families of Hospitalized Children
10. Deane F. Johnson Center Receives Ronald and Nancy Reagan Award
11. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6